Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4280-4286

  Boltze, Carsten ^a   Mundschenk, Jochen ^a   Unger, Nicole ^a   Schneider Stock, Regine ^a   Peters, Brigitte ^a   Mawrin, Christian ^a   Hoang Vu, Cuong ^b   Roessner, Albert ^a   Lehnert, Hendrik ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; TELOMERASE;

ADRENAL MEDULLA; ADULT; AGED; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA CONFORMATION; TELOMERE; UPREGULATION;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC MARKERS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHEOCHROMOCYTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TELOMERASE;

EID: 0141787950     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021299     Document Type: Article

References (39)

1. Linnoila RI, Keiser HR, Steinberg SM, Lack EE 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas. Clinicopathologic study of 120 cases including unusual histological features. Hum Pathol 21:1168-1180
2. Clarke MR, Weyant RJ, Watson CG, Carty SE 1998 Prognostic markers in pheochromocytoma. Hum Pathol 28:522-526
3. Salmenkivi K, Haglund C, Ristimatl A, Arola J, Heikkila P 2001 Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab 86:5615-5619
4. Mundschenk J, Lehnert H 1998 Malignant pheochromocytoma. Exp Clin Endocrinol Diabetes 106:373-376
5. Zakian VA 1996 Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 30:141-172
6. Wellinger RJ, Sen D 1997 The DNA structures at the ends of eukaryotic chromosomes. Eur J Cancer 33:735-749
7. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB 1992 Telomere end-replication problem and cell aging. J Mol Biol 225:951-960
8. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider GW, Villeponteau B 1995 The RNA component of human telomerase. Science 269:1236-1241
9. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW 1996 Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650
10. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR 1997 Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959
11. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW, Wright WE, White MA 1999 Functional requirement of p23 and hsp90 in telomerase complexes. Genes Dev 13:817-826
12. Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S 2000 Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J Biol Chem 275:22568-22573
13. Lundblad V 1998 Telomerase catalysis: a phylogenetically conserved reverse transcriptase. Proc Natl Acad Sci 95:8415-8416
14. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO 1997 A mammalian telomerase-associated protein. Science 275:973-977
15. Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R 1996 Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 93:6091-6095
16. Remmele W, Hildebrand U, Hienz H 1986 Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors and Barr bodies in human breast cancer. Virchow Arch 409:127-147
17. Kim NW, Wu F 1997 Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25:2595-2597
18. Glodny B, Winde G, Herwig R, Meier A, Kuhle C, Cromme S, Vetter H 2001 Clinical differences between benign and malignant pheochromocytomas. Endocr J 48:151-159
19. John H, Ziegler W, Hauri D, Jaeger P 1999 Pheochromocytomas: Can malignant potential be predicted? Urology 53:679-683
20. Helman LJ, Cohen PS, Averbuch SD, Cooper MJ, Keiser HR, Israel MH 1989 Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma. J Clin Oncol 7:1270-1275
21. Rao F, Keiser HR, O'Connor DT 2000 Malignant pheochromocytoma: chromaffin granule transmitter and response to treatment. Hypertension 36:1045-4052
22. Komminoth P, Kunz E, Hiort O, Schroder S, Matias-Guiu X, Christiansen G, Roth J, Heitz PH 1994 Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single strand conformation polymorphism analysis and direct sequencing. Am J Pathol 145:922-929
23. Bamberger CM, Else T, Bamberger AM, Frilling A, Beil FU, Allolio B, Schulte HM 1999 Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 107:272-275
24. Kinoshita H, Ogawa O, Mishina M, Oka H, Okumura K, Yamabe H, Terachi T, Yoshida O 1998 Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features. Urol Res 26:29-32
25. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K 1998 Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82:176-179
26. Shay JW, Bacchetti S 1997 A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791
27. Okayasu I, Mitomi H, Yamashita K, Mikami T, Fujiwara M, Kato M, Oshimura M 1998 Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas. J Cancer Res 124:444-449
28. Katayama S, Shiota G, Oshimura M, Kawasaki H 1999 Clinical usefulness of telomerase activity in the preoperative diagnosis of gastric and colorectal cancer. J Cancer Res 125:405-410
29. Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B 1998 Telomerase activity in human proliferative breast lesions. Int J Oncol 12:641-648
30. Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Köhrle J, Rath FW, Dralle H 2002 Expression of telomerase genes in thyroid carcinoma. Int J Oncol 21:265-272
31. Schneider-Stock R, Boltze C, Jäger V, Epplen J, Landt O, Peters B, Rys J, Roessner A 2003 Elevated telomerase activity, c-Myc, and hTERT mRNA expression: markers for tumor progression in malignant lipomatcus tumors. J Pathol 199:517-525
32. Harley CB 1991 Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991 256:271-282
33. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R 1998 Expression profile of the putative catalytic subunit of telomerase gene. Cancer Res 58:622-625
34. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa FU 1998 Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65-68
35. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW 1995 Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249-255
36. Aogi K, Kitahara K, Buley M, Backdahl M, Tahara H, Sugino T, Tarin D, Goodison S 1998 Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin Cancer Res 4:1965-1970
37. Saji M, Xydas S, Westra WH, Liang CK, Clark DP, Udelsman R, Umbricht CB, Sukumar S, Zeiger MA 1999 Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 5:1483-1489
38. Chang JTC, Chen YL, Yang HAT, Chen CY, Cheng AJ 2002 Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 269:3442-3450
39. Hutchinson KA, Stancato LF, Owens-Grillo JK, Johnson JL, Krishna P, Toft DO, Pratt WB 1995 The 23-kDa acidic protein in reticulocyte lysate is the weakly bound component of the hsp foldosome that is required for assembly of the glucocorticoid receptor into a functional heterocomplex with HSP90. J Biol Chem 270:18841-18847